In this study, we innovatively fused ELP to ASP with the assistance of AlphaFold2 and revealed multiple benefits of the designed ASP‐ELPs over ASP and PEGylated ASP (trade name Oncaspar) in treating leukemia and lymphoma. The gene discussed is NR5A1; the disease is leukemia.